TY  - BOOK
AU  - Engy Ali Elsayed Mansour 
AU  - Hesham Aly Salem , 
AU  - Sherifa Kamal Ahmed , 
AU  - Suzan Mohamed Mansour , 
TI  - Study of the possible role of cAMP and KATP channels in atorvastatin-induced hepatotoxicity / 
PY  - 2019///
CY  - Cairo : 
PB  - Engy Ali Elsayed Mansour , 
KW  - cAMP and KATP
KW  - cAMP and KATP channels
KW  - Hepatotoxicity
N1  - Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology; Issued also as CD
N2  - Atorvastatin (ATO), a 3-hydroxy-3-methylglutryl-CoA reductase inhibitor, is used widely for treatment of hypercholesterolemia and hypertriglyceridemia. The full clinical utility of ATO has now been somehow limited because of ATO-associated several acute and chronic side effects.The aim of the present work was to investigate the possible mechanism by which cyclic adenosine monophosphate (cAMP) induction  or KATP channel opening might affect ATO-induced hepatotoxicity.1- Preliminary study: to determine the most appropriate hepatotoxic regimen (dose and duration) of ATO,depending on measuring alanine transaminase (ALT) and aspartate transaminase (AST) in addition to histopathological liver examination, was performed
ER  -